Kouskoff V, Lacaud G, Pape K, Retter M, Nemazee D
Division of Basic Sciences, Department of Pediatrics, National Jewish Medical and Research Center, Denver, CO 80206, USA.
Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7435-9. doi: 10.1073/pnas.130182597.
During B lymphocyte development, antibody genes are assembled by DNA recombination. Successful cell surface expression of IgM promotes developmental progression. However, when antigen receptors bind autoantigen, development is blocked and ongoing antibody gene recombination occurs, which often alters antibody specificity in a process called receptor editing. We demonstrate here a significant role of developmental block and receptor editing in B cell receptor quality control. During development a functional, non-self-reactive receptor undergoes receptor editing if its expression is below a certain threshold. Doubling the receptor gene dose promotes development in the absence of autoantigen, but allows editing when autoantigen is present. Thus, both underexpressed and harmful B cell receptors can undergo correction by receptor editing.
在B淋巴细胞发育过程中,抗体基因通过DNA重组进行组装。IgM在细胞表面的成功表达促进发育进程。然而,当抗原受体结合自身抗原时,发育受阻,同时会发生持续的抗体基因重组,这一过程通常会在一种称为受体编辑的过程中改变抗体特异性。我们在此证明了发育阻滞和受体编辑在B细胞受体质量控制中的重要作用。在发育过程中,如果功能性非自身反应性受体的表达低于一定阈值,它会经历受体编辑。在没有自身抗原的情况下,将受体基因剂量加倍可促进发育,但当存在自身抗原时则允许编辑。因此,表达不足和有害的B细胞受体都可以通过受体编辑进行校正。